Posts By: pharmanewsdaily

Uncategorized

Novo Nordisk bags Rybelsus FDA approval for type 2 diabetes

Rybelsus FDA approval : Danish pharma company Novo Nordisk has bagged approval from the US Food and Drug Administration (FDA) for Rybelsus (semaglutide) oral tablets for its use in patients with type 2 diabetes. The FDA approval for Rybelsus is to improve control of blood sugar in addition to diet and exercise in adults having […]

The post Novo Nordisk bags Rybelsus FDA approval for type 2 diabetes appeared first on PharmaNewsDaily.com.

Uncategorized

Opentrons launches fully automated thermocycler at $4,000

Biotech startup Opentrons has launched a fully automated thermocycler, priced at $4,000, which has been designed to help biologists with automated end-to-end PCR based workflow. According to Opentrons, there are several products that are currently available in the market which enable biologists to automate important segments of their workflows. However, human assistance is needed for […]

The post Opentrons launches fully automated thermocycler at $4,000 appeared first on PharmaNewsDaily.com.

Uncategorized

Aptorum to develop drugs for treatment of obesity and neuroblastoma

Aptorum Group said that it will undertake the development of CLS-1 microbiome drug candidate and certain repurposed drug candidates for the treatment of obesity and neuroblastoma, respectively. Based in Hong Kong, Aptorum Group is a pharma company focused on the development of new drugs to treat unmet medical needs. The company said that its wholly-owned subsidiary […]

The post Aptorum to develop drugs for treatment of obesity and neuroblastoma appeared first on PharmaNewsDaily.com.

Uncategorized

Mindmed acquires 18-MC opioid addiction drug candidate from Savant HWP

Mindmed acquisition of 18-MC : Canada-based Mind Medicine (Mindmed) has acquired opioid addiction drug candidate 18-MC from Savant HWP for an undisclosed price, as per the latest pharma acquisition news. 18-MC, which is derived from ibogaine – a natural psychedelic substance, is being developed for addressing the opioid crisis and other types of addiction. The […]

The post Mindmed acquires 18-MC opioid addiction drug candidate from Savant HWP appeared first on PharmaNewsDaily.com.

Uncategorized

Cutera truSculpt iD body sculpting treatment gets expanded approval in Canada

Cutera said that Health Canada has expanded approval for its truSculpt iD body sculpting treatment to cover its use for the reduction of circumference of the abdomen and non-invasive lipolysis, which is the permanent removal of fat cells from the body. According to American Society for Aesthetic Plastic Surgery and Medical Insight (MII), noninvasive body sculpting […]

The post Cutera truSculpt iD body sculpting treatment gets expanded approval in Canada appeared first on PharmaNewsDaily.com.

Uncategorized

RESTORE clinical trial of STR001 : Strekin completes patient enrollment

RESTORE clinical trial of STR001 : Swiss biopharma company Strekin has wrapped up patient enrollment in a phase 3 study, called RESTORE, for evaluating its small molecule STR001 in patients after a sudden sensorineural hearing loss (SSNHL) event. The late-stage trial is a global, randomized, placebo-controlled study, which will feature 165 patients at nearly 25 […]

The post RESTORE clinical trial of STR001 : Strekin completes patient enrollment appeared first on PharmaNewsDaily.com.

Uncategorized

CroĆ­Valve set to advance Tricuspid Coaptation Valve into clinical trial

CroíValve, an Irish medtech company spun out from Trinity College, has raised €4 million for developing a medical device called Tricuspid Coaptation Valve for the treatment of tricuspid regurgitation (TR), a severe heart condition. The financing secured by the Irish medtech firm includes €2.5 million from the European Union under its Horizon 2020 SME Instrument […]

The post CroíValve set to advance Tricuspid Coaptation Valve into clinical trial appeared first on PharmaNewsDaily.com.

Uncategorized

Aytu BioScience to acquire Innovus Pharmaceuticals

Aytu acquisition of Innovus : Colorado-based specialty pharma company Aytu BioScience has agreed to acquire Innovus Pharmaceuticals in a deal worth up to $24 million, as per the latest pharma acquisition news. Headquartered in California, Innovus Pharmaceuticals is an over the counter (OTC) consumer goods and specialty pharmaceutical company. On the other hand, Aytu BioScience […]

The post Aytu BioScience to acquire Innovus Pharmaceuticals appeared first on PharmaNewsDaily.com.

Uncategorized

Lilly teams up with ImmuNext for developing drugs for autoimmune diseases

US pharma giant Eli Lilly and Company (Lilly) and Lebanon-based ImmuNext have announced a global licensing and research collaboration for

The post Lilly teams up with ImmuNext for developing drugs for autoimmune diseases appeared first on PharmaNewsDaily.com.

The post Lilly teams up with ImmuNext for developing drugs for autoimmune diseases appeared first on Business News Today.

Scroll To Top